NO964561L - Tri-, tetra-, penta-, og polypeptider, og bruken av disse som antidepressiv agent - Google Patents

Tri-, tetra-, penta-, og polypeptider, og bruken av disse som antidepressiv agent

Info

Publication number
NO964561L
NO964561L NO964561A NO964561A NO964561L NO 964561 L NO964561 L NO 964561L NO 964561 A NO964561 A NO 964561A NO 964561 A NO964561 A NO 964561A NO 964561 L NO964561 L NO 964561L
Authority
NO
Norway
Prior art keywords
residues
penta
polypeptides
tetra
tri
Prior art date
Application number
NO964561A
Other languages
English (en)
Other versions
NO964561D0 (no
NO317919B1 (no
Inventor
Henry B Abajian
John F Noble
Joseph J Hlavka
Original Assignee
Innapharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innapharma Inc filed Critical Innapharma Inc
Publication of NO964561D0 publication Critical patent/NO964561D0/no
Publication of NO964561L publication Critical patent/NO964561L/no
Publication of NO317919B1 publication Critical patent/NO317919B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19964561A 1994-05-04 1996-10-28 Tri-, tetra-, penta-, og polypeptider samt deres anvendelse for fremstilling av et farmasoytisk preparat til behandling av depresjon NO317919B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/238,089 US5589460A (en) 1994-05-04 1994-05-04 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
PCT/US1995/005560 WO1995030430A1 (en) 1994-05-04 1995-05-02 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent

Publications (3)

Publication Number Publication Date
NO964561D0 NO964561D0 (no) 1996-10-28
NO964561L true NO964561L (no) 1996-12-27
NO317919B1 NO317919B1 (no) 2005-01-03

Family

ID=22896449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964561A NO317919B1 (no) 1994-05-04 1996-10-28 Tri-, tetra-, penta-, og polypeptider samt deres anvendelse for fremstilling av et farmasoytisk preparat til behandling av depresjon

Country Status (16)

Country Link
US (1) US5589460A (no)
EP (1) EP0759772B1 (no)
JP (1) JP3878983B2 (no)
CN (1) CN1150028C (no)
AT (1) ATE258061T1 (no)
AU (1) AU685292B2 (no)
CA (1) CA2189145C (no)
DE (1) DE69532470T2 (no)
DK (1) DK0759772T3 (no)
ES (1) ES2215175T3 (no)
FI (1) FI964363A (no)
MY (1) MY113407A (no)
NO (1) NO317919B1 (no)
PT (1) PT759772E (no)
RU (1) RU2182910C2 (no)
WO (1) WO1995030430A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093797A (en) * 1994-05-04 2000-07-25 Innapharma, Inc. Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5792466A (en) * 1996-12-13 1998-08-11 The United States Of America, As Represented By The Secretary Of Agriculture Mimetic insect kinin analogs for insect control
AU8912698A (en) * 1997-08-19 1999-03-08 University Of Medicine And Dentistry Of New Jersey Inhibition of hiv-1 replication using d-amino acid peptides
US6150420A (en) * 1998-06-01 2000-11-21 Theramax, Inc. Method for enhanced brain delivery of bupropion
KR101155740B1 (ko) 2004-03-31 2012-06-12 톳쿄기쥬츠 가이하츠 가부시키가이샤 상피계 세포증식 촉진제
CN104083752B (zh) * 2007-06-27 2018-04-10 里兰斯坦福初级大学理事会 寡肽酪氨酸酶抑制剂及其应用
JP5568008B2 (ja) * 2007-06-27 2014-08-06 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ペプチドチロシナーゼインヒビターおよびその使用
CN101284868A (zh) * 2008-05-26 2008-10-15 刘刚 一种肽水合盐类化合物及其立体异构体
CN108690121B (zh) * 2017-04-07 2020-05-15 深圳翰宇药业股份有限公司 一种奈米非肽液相制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3708593A (en) * 1971-08-24 1973-01-02 Abbott Lab Use of l-prolyl l-leucyl glycine amide as an anti-depressant
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3795738A (en) * 1972-12-26 1974-03-05 Abbott Lab Use of l-propyl l-leucyl glycine amide to treat parkinson's disease
US3931184A (en) * 1974-10-31 1976-01-06 Abbott Laboratories Purification method for prolyl-leucylglycinamide
US4018912A (en) * 1975-07-28 1977-04-19 Ayerst Mckenna And Harrison Ltd. Tripeptide derivatives with central nervous system activity and preparation thereof
US4278595A (en) * 1979-12-10 1981-07-14 Vega Laboratories, Inc. Orally active MIF analogs with an effect on the central nervous system
JPS5830299B2 (ja) * 1981-10-30 1983-06-28 三菱化学株式会社 トリペプチドおよびその誘導体
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
JP3349528B2 (ja) * 1992-08-14 2002-11-25 株式会社日清製粉グループ本社 ペプチド

Also Published As

Publication number Publication date
PT759772E (pt) 2004-06-30
EP0759772A4 (en) 1999-04-21
DK0759772T3 (da) 2004-06-01
DE69532470T2 (de) 2004-10-21
EP0759772A1 (en) 1997-03-05
EP0759772B1 (en) 2004-01-21
ATE258061T1 (de) 2004-02-15
ES2215175T3 (es) 2004-10-01
RU2182910C2 (ru) 2002-05-27
AU685292B2 (en) 1998-01-15
MY113407A (en) 2002-02-28
CA2189145A1 (en) 1995-11-16
JP3878983B2 (ja) 2007-02-07
FI964363A (fi) 1996-12-23
FI964363A0 (fi) 1996-10-29
JPH10500407A (ja) 1998-01-13
AU2813995A (en) 1995-11-29
NO964561D0 (no) 1996-10-28
US5589460A (en) 1996-12-31
DE69532470D1 (de) 2004-02-26
CN1150028C (zh) 2004-05-19
WO1995030430A1 (en) 1995-11-16
NO317919B1 (no) 2005-01-03
CN1151700A (zh) 1997-06-11
CA2189145C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
DE69326064T2 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
PT1105409E (pt) Proteccao de peptidos terapeuticos endogenos da actividade de peptidases por conjugacao a componentes do sangue
DK1918298T3 (da) Peptid
NO964561D0 (no) Tri-, tetra-, penta-, og polypeptider, og bruken av disse som antidepressiv agent
FR2837098B1 (fr) Composition cosmetique ou pharmaceutique comprenant des peptides, procedes de traitement et utilisations
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
CO5601035A2 (es) Peptidos tolerogenicos de la proteina basica de mielina
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
WO1994026903A3 (en) Human influenza virus peptides binding hla-i molecule
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
DK1012175T3 (da) Peptid med affinitet til koagulationsfaktor VIII
ATE42308T1 (de) Pharmakologisch aktive peptide.
MY140828A (en) Therapeutic uses of tri-, tetra-, penta-, and polypeptides
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
ATE25984T1 (de) Pharmakologisch aktive peptide.
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
ATE305478T1 (de) Topoisomerase-ii inhibitoren
IL150045A0 (en) Compositions and methods for detecting stress-inducible proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)